New injectable treatment with laser for hidradenitis suppurativa
Part of Infections, Skin clinical trials.
This study tests a combination of an injection (anti-IL-17A/F monoclonal antibody) and a special laser treatment for hidradenitis suppurativa (HS), a painful skin condition with recurring lumps and abscesses. You'll be followed closely to see if this combination helps reduce your symptoms and improves your skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with mild to moderate hidradenitis suppurativa (Hurley stage I or II)
- Have at least 3 abscesses or inflammatory nodules across one or more body areas
- Antibiotics haven't worked well enough for you, or your condition came back after stopping them
- Never received biologic drugs or targeted small-molecule drugs before
- No tunnels or cavities visible on ultrasound of your skin lesions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a 1726-nm laser to reduce inflamed nodules in people with mild to moderate hidradenitis suppurativa (HS). It compares treated and untreated areas to see if the laser helps without affecting the rest of the body.
This trial is testing an experimental tablet called LT-002-158 in adults with moderate to severe hidradenitis suppurativa (HS) that hasn't improved enough with standard treatments. The goal is to see if it's safe and helps reduce painful lumps and abscesses.
This trial tests a new treatment that blocks a specific immune signal (interferon type 1) to see if it can help people with severe hidradenitis suppurativa who have not gotten better with standard treatments and need strong pain medication.
This study tests whether botulinum toxin (Botox) injections can improve hidradenitis suppurativa (a painful skin condition with lumps and abscesses). It may be an option for people who have not improved with antibiotics.
This trial tests an investigational medicine, SPY072, for adults with moderate to severe hidradenitis suppurativa (also known as HS), a skin condition that causes painful lumps and sores. If you join, you'll help see if this treatment is safe and effective.
This trial looks at a type of immune cell (MAIT cells) in people with hidradenitis suppurativa (a skin condition causing painful bumps). It aims to understand how these cells work and how they relate to treatments like adalimumab, secukinumab, or bimekizumab. You may be able to join if you have moderate-to-severe HS and are about to start one of these treatments.
Hear when a new Hidradenitis Suppurativa (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.